Articles tagged "Kidney transplantation"

2018 American Transplant Congress
Durable Donor Hematopoetic Stem Cell (HSC) Chimerism is Associated with Protection from Native Renal Disease Recurrence in Recipients of Combined HSC/Kidney Transplants
J. Leventhal,¹ L. Gallon,¹ J. Mathew,¹ J. Miller,¹ D. Stare,¹ S. Ildstad.²
¹Northwestern U, Chicago; ²U Louisville, Louisville.
Recurrence of the original cause of ESRD has been observed in trials of tolerance induction for kidney transplantation (KTx) where donor HSC have been used…
2018 American Transplant Congress
Outcomes in Renal Transplant Recipients with Bipolar Disorder: A Large Retrospective Cohort
S. Hamel,¹ D. Sawinski,² R. Weinrieb,³ S. Dave,³ J. Trofe-Clark.^1,2
¹Pharmacy, Hosp of Univ. of Pennsylvania, Philadelphia; ²Renal Division, Perelman School of Medicine, Univ. of Pennsylvania, Philadelphia; ³Dept of Psychiatry, Perelman School of Medicine, Univ. of Pennsylvania, Philadelphia.
Purpose: Management of renal transplant recipients (RTRs) with bipolar disorder (BD) is complicated by risk factors for non-adherence, complex medication regimens and limited published guidance.…
2018 American Transplant Congress
Long-Term Follow-Up of Pediatric Kidney Recipients Who Received Alemtuzumab Induction
D. Harriman, A. Chen, J. Rogers, R. Stratta, G. Orlando, A. South, J-.J. Lin, A. Farney.
Surgery, Pediatrics, Cardiovascular Sciences Center, Wake Forest Baptist Medical Center, Winston-Salem, NC.
Introduction: Experience with alemtuzumab (alem) depleting antibody induction has rarely been studied in the pediatric population, and reports that exist have limited follow-up. The purpose…
2018 American Transplant Congress
Long-Term Outcome of Pediatric Kidney Transplantation: A Single-Center Experience over the past Three Decades in Japan
Y. Aoki,¹ H. Satoh,¹ Z. Matsui,¹ R. Hamada,² Y. Hamasaki,³ S. Shishido.³
¹Urology and Kidney Transplantation, Tokyo Metropolitan Children's Medical Center, Fuchu-shi, Tokyo, Japan; ²Nephrology, Tokyo Metropolitan Children's Medical Center, Fuchu-shi, Tokyo, Japan; ³Nephrology, Toho University Faculty of Medicine, Ota-ku, Tokyo, Japan.
Purpose: Kidney transplantation (KTx) is the preferred treatment for children with ESRD. Although the steady advances in immunosuppression have enabled control of early acute rejection…
2018 American Transplant Congress
Overcoming Barriers to Transplant: An A2 to B Program Need Not Be Difficult, Expensive, or Time Consuming Even for Large Centers
S. Radomski, B. Diedrich, D. Li, M. Awwad, S. Rosen-Bronson, A. Langeberg, A-.A. Hamby, M. Cooper, A. Gilbert.
Medstar Georgetown Transplant Institute, Medstar Georgetown University Hospital, Washington, DC.
Introduction. Since the implementation of the new Kidney Allocation System (KAS) few centers have implemented the use of A2 donor kidneys into B recipients. Centers…
2018 American Transplant Congress
Scoring Transplant Glomerulopathy Using Morphometry: Correlation with Banff Criteria
M. Morales, A. Denic, W. Park, B. Smith, M. Alexander, M. Stegall.
William J.von Liebig Transplant Center, Mayo Clinic, Rochester, MN.
Background: Transplant glomerulopathy (TG) is a prognostic marker for graft survival. Still, scoring TG using the Banff cg-score remains a challenge and no assessments in…
2018 American Transplant Congress
Early Graft Function Correlates with Survival Benefit in Kidney Transplant Recipients with Peripheral Vascular Disease
E. Min, V. Tatapudi, N. Ali, B. Gelb, N. Dagher, J. Benstein, R. Montgomery, B. Lonze.
NYU Langone Medical Center, New York, NY.
Objective: Peripheral vascular disease (PVD) is common among end-stage renal disease (ESRD) patients and is a known independent risk factor for increased post-transplant mortality. The…
2018 American Transplant Congress
Early Conversion to a CNI-Free Immunosuppression with SRL after Renal Tx – 10 yr Follow-Up Analysis of a Prospective Multicenter Trial
J. Andrassy,¹ M. Guba,¹ A. Habicht,² M. Fischereder,³ A. Pascher,⁴ K. Heller,⁵ B. Banas,⁶ O. Hakenberg,⁷ T. Vogel,⁸ T. Kauke.¹
¹Surgery, Ludwig-Maximilans-University, Munich, Germany; ²Transplant, Ludwig-Maximilans-University, Munich, Germany; ³Nephrology, MED IV, Ludwig-Maximilans-University, Munich, Germany; ⁴Surgery, Charitée University, Berlin, Germany; ⁵Medicine, University of Erlangen, Erlangen, Germany; ⁶Internal Medicine II, University of Regensburg, Regensburg, Germany; ⁷Urology, University of Rostock, Rostock, Germany; ⁸Surgery, University of Munster, Munster, Germany.
Introduction: A prospective multicenter trial comparing an early conversion to a CNI-free immunosuppression with SRL, MMF and steroids with a conventional CsA treatment following renal…
2018 American Transplant Congress
CMV and BKV Infections after Kidney Transplantation: Combined Tacrolimus/everolimus Strategy Using Antithymocyte Globulin Induction
T. Jouve,^1,4 R. Germi,^2,4 B. Janbon,¹ G. Fiard,^3,4 P. Malvezzi,¹ L. Rostaing.^1,4
¹Nephrology, Dialysis, Apheresis, Transplantation Unit, Grenoble University Hospital, Grenoble, France; ²Virology Unit, Grenoble University Hospital, Grenoble, France; ³Urology Unit, Grenoble University Hospital, Grenoble, France; ⁴Medical Sciences, Grenoble University, Grenoble, France.
Cytomegalovirus (CMV) and BK Virus (BKV) infections are frequent complications after kidney transplantation. A combined regimen of calcineurin inhibitor (CNI) and mTOR inhibitors (mTORi) reduces…
2018 American Transplant Congress
Mycophenolate Monotherapy is Safe and Effective in HLA-Matched Kidney Transplant Recipients
A. Hennes, K. Holdener, W. Burlingham, B. Astor, A. Djamali.
UW Health, Madison, WI.
Purpose: The ideal minimizing strategy for maintenance immunosuppression in HLA-matched kidney transplant recipients (KTR) is unknown. We hypothesized that mycophenolate (MPA) monotherapy is a safe…